{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:35Z","timestamp":1792782875815,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Inonu University","id":[{"id":"https:\/\/ror.org\/04asck240","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Vancomycin-resistant enterococci (VRE) represent a major challenge in healthcare settings due to limited therapeutic options and the emergence of resistance to last-line agents. Accurate detection of resistance mechanisms and understanding the molecular epidemiology of circulating strains are essential for effective surveillance and infection control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 192 non-duplicate\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      isolates (103 VRE and 89 vancomycin-susceptible isolates) recovered from clinical specimens between 2018 and 2022 were analyzed. Antimicrobial susceptibility testing was performed using broth microdilution (BMD) as the reference method and compared with automated and gradient-based methods. Resistance genes associated with vancomycin and linezolid resistance were investigated by in-house PCR and sequencing. Clonal relatedness of VRE isolates was assessed using AP-PCR, PFGE, and MLST.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among VRE isolates,\n                      <jats:italic>vanA<\/jats:italic>\n                      was the predominant resistance determinant, while a single isolate carried\n                      <jats:italic>vanB<\/jats:italic>\n                      . Importantly,\n                      <jats:italic>vanA<\/jats:italic>\n                      was also detected in three phenotypically vancomycin-susceptible\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      isolates, consistent with vancomycin-variable enterococci. Linezolid resistance was identified in three isolates (1.6%); two\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      isolates harbored the transferable\n                      <jats:italic>optrA<\/jats:italic>\n                      gene, representing the first report of\n                      <jats:italic>optrA<\/jats:italic>\n                      -positive\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      causing human infections in T\u00fcrkiye, while one\n                      <jats:italic>E. faecium<\/jats:italic>\n                      isolate showed linezolid resistance in the absence of the investigated resistance genes. Tigecycline resistance was uncommon. Daptomycin retained in vitro activity with higher MIC\u2085\u2080\/ MIC\u2089\u2080 values in\n                      <jats:italic>E. faecium<\/jats:italic>\n                      , whereas oritavancin MIC values were higher among\n                      <jats:italic>E. faecalis<\/jats:italic>\n                      isolates. The BD Phoenix system demonstrated high categorical agreement with BMD for vancomycin and teicoplanin but generated major and very major errors for linezolid susceptibility testing. Molecular typing revealed extensive genetic diversity among VRE isolates, with 35 AP-PCR genotypes, PFGE-confirmed clustering including one predominant clone, and the identification of 11 novel MLST sequence types (ST2994\u2013ST3004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study provides insight into the resistance landscape and genetic diversity of clinical\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      isolates. The detection of vancomycin-variable enterococci and transferable linezolid resistance determinants underscores the need for integrated phenotypic and molecular approaches to ensure accurate resistance detection and effective surveillance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-026-05556-8","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:08:02Z","timestamp":1780394882000},"page":"2791-2800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of resistance mechanisms and susceptibility testing in Enterococcus spp.: implications of vancomycin-variable isolates and optrA-mediated resistance"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-0874","authenticated-orcid":false,"given":"Mervenur","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-1279","authenticated-orcid":false,"given":"Aylin \u0130rem","family":"Ocakl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0449-0356","authenticated-orcid":false,"given":"Elif Seren","family":"Tanr\u0131verdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4546-9729","authenticated-orcid":false,"given":"G\u00fcl\u015fen","family":"Haz\u0131rolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-7590","authenticated-orcid":false,"given":"Alpaslan","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-0521","authenticated-orcid":false,"given":"Bar\u0131\u015f","family":"Otlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0724-3166","authenticated-orcid":false,"given":"Bur\u00e7in","family":"\u015eener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"5556_CR1","doi-asserted-by":"publisher","unstructured":"Fiore E, Van Tyne D, Gilmore Michael S (2019) Pathogenicity of Enterococci. Microbiol Spectr 7(4). https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0053-2018","DOI":"10.1128\/microbiolspec.GPP3-0053-2018"},{"issue":"5","key":"5556_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck BL, Rice LB (2012) Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 3(5):421\u2013433. https:\/\/doi.org\/10.4161\/viru.21282","journal-title":"Virulence"},{"issue":"9","key":"5556_CR3","doi-asserted-by":"publisher","first-page":"e00843","DOI":"10.1128\/jcm.00843-21","volume":"60","author":"A Khan","year":"2022","unstructured":"Khan A, Miller William R, Axell-House D et al (2022) Antimicrobial Susceptibility Testing for Enterococci. J Clin Microbiol 60(9):e00843\u2013e00821. https:\/\/doi.org\/10.1128\/jcm.00843-21","journal-title":"J Clin Microbiol"},{"key":"5556_CR4","unstructured":"WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO.; 2024"},{"key":"5556_CR5","unstructured":"ECDC European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) -Annual Epidemiological Report 2023. Stockholm; 2024"},{"key":"5556_CR6","unstructured":"ECDC-WHO Antimicrobial resistance surveillance in Europe 2023\u2009\u2013\u20092021 data. Stockholm: European Centre for Disease Prevention and Control and World Health Organization; 2023"},{"key":"5556_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jgar.2025.01.016","volume":"41","author":"AC Almeida-Santos","year":"2025","unstructured":"Almeida-Santos AC, Novais C, Peixe L et al (2025) Vancomycin-resistant Enterococcus faecium: A current perspective on resilience, adaptation, and the urgent need for novel strategies. J Global Antimicrob Resist 41:233\u2013252. https:\/\/doi.org\/10.1016\/j.jgar.2025.01.016","journal-title":"J Global Antimicrob Resist"},{"issue":"7","key":"5556_CR8","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1128\/AAC.00286-16","volume":"60","author":"A Sivertsen","year":"2016","unstructured":"Sivertsen A, Pedersen T, Larssen KW et al (2016) A Silenced vanA Gene Cluster on a Transferable Plasmid Caused an Outbreak of Vancomycin-Variable Enterococci. Antimicrob Agents Chemother 60(7):4119\u20134127. https:\/\/doi.org\/10.1128\/AAC.00286-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"5556_CR9","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1128\/AAC.46.10.3334-3336.2002","volume":"46","author":"SH Marshall","year":"2002","unstructured":"Marshall SH, Donskey CJ, Hutton-Thomas R et al (2002) Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 46(10):3334\u20133336. https:\/\/doi.org\/10.1128\/AAC.46.10.3334-3336.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5556_CR10","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1128\/AAC.01633-08","volume":"53","author":"L Boumghar-Bourtcha\u00ef","year":"2009","unstructured":"Boumghar-Bourtcha\u00ef L, Dhalluin A, Malbruny B et al (2009) Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. Antimicrob Agents Chemother 53(9):4007\u20134009. https:\/\/doi.org\/10.1128\/AAC.01633-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"5556_CR11","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/jac\/dkac263","volume":"77","author":"A Brenciani","year":"2022","unstructured":"Brenciani A, Morroni G, Schwarz S et al (2022) Oxazolidinones: mechanisms of resistance and mobile genetic elements involved. J Antimicrob Chemother 77(10):2596\u20132621. https:\/\/doi.org\/10.1093\/jac\/dkac263","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5556_CR12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/jac\/dkaa075","volume":"75","author":"SA Egan","year":"2020","unstructured":"Egan SA, Shore AC, O\u2019Connell B et al (2020) Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds. J Antimicrob Chemother 75(7):1704\u20131711. https:\/\/doi.org\/10.1093\/jac\/dkaa075","journal-title":"J Antimicrob Chemother"},{"key":"5556_CR13","unstructured":"ISO, 20776-1, Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices\u2014Part 1: Broth Micro-Dilution Reference Method For Testing the in Vitro Activity of Antimicrobial Agents Against Rapidly Growing Aerobic Bacteria Involved in Infectious Diseases. 2019; Edition 2"},{"key":"5556_CR14","unstructured":"EUCAST The European Committee on Antimicrobial Susceptibility Testing. Clinical Breakpoints, Version 15.0; 2025"},{"key":"5556_CR15","unstructured":"Clinical and Laboratory Standards Institute (2025) Performance standards for antimicrobial susceptibility testing: thirty-fifth edition. CLSI supplement M100. Wayne, PA, USA"},{"key":"5556_CR16","volume-title":"31A, Verification and Validation of Procedures in the Clinical Microbiology Laboratory","author":"Cumitech","year":"2009","unstructured":"Cumitech (2009) In: Sharp SE (ed) 31A, Verification and Validation of Procedures in the Clinical Microbiology Laboratory, Coordinating edn. ASM, Washington, DC","edition":"Coordinating"},{"issue":"Pt 1","key":"5556_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1099\/jmm.0.05353-0","volume":"53","author":"R Creti","year":"2004","unstructured":"Creti R, Imperi M, Bertuccini L et al (2004) Survey for virulence determinants among Enterococcus faecalis isolated from different sources. J Med Microbiol 53(Pt 1):13\u201320. https:\/\/doi.org\/10.1099\/jmm.0.05353-0","journal-title":"J Med Microbiol"},{"issue":"1","key":"5556_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/jcm.33.1.24-27.1995","volume":"33","author":"S Dutka-Malen","year":"1995","unstructured":"Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33(1):24\u201327. https:\/\/doi.org\/10.1128\/jcm.33.1.24-27.1995","journal-title":"J Clin Microbiol"},{"issue":"4","key":"5556_CR19","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1128\/AAC.50.4.1156-1163.2006","volume":"50","author":"C Kehrenberg","year":"2006","unstructured":"Kehrenberg C, Schwarz S (2006) Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 50(4):1156\u20131163. https:\/\/doi.org\/10.1128\/AAC.50.4.1156-1163.2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5556_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/jac\/dkv341","volume":"71","author":"A Brenciani","year":"2016","unstructured":"Brenciani A, Morroni G, Pollini S et al (2016) Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy. J Antimicrob Chemother 71(2):307\u2013313. https:\/\/doi.org\/10.1093\/jac\/dkv341","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5556_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/jac\/dky505","volume":"74","author":"A Brenciani","year":"2019","unstructured":"Brenciani A, Fioriti S, Morroni G et al (2019) Detection in Italy of a porcine Enterococcus faecium isolate carrying the novel phenicol-oxazolidinone-tetracycline resistance gene poxtA. J Antimicrob Chemother 74(3):817\u2013818. https:\/\/doi.org\/10.1093\/jac\/dky505","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5556_CR22","first-page":"401","volume":"31","author":"C Kuzucu","year":"2008","unstructured":"Kuzucu C, Durmaz R, Otlu B et al (2008) Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. New Microbiol 31(3):401\u2013408","journal-title":"New Microbiol"},{"issue":"11","key":"5556_CR23","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1128\/JCM.38.11.4242-4245.2000","volume":"38","author":"D Turabelidze","year":"2000","unstructured":"Turabelidze D, Kotetishvili M, Kreger A et al (2000) Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 38(11):4242\u20134245. https:\/\/doi.org\/10.1128\/JCM.38.11.4242-4245.2000","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5556_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1128\/JCM.40.6.1963-1971.2002","volume":"40","author":"WL Homan","year":"2002","unstructured":"Homan WL, Tribe D, Poznanski S et al (2002) Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 40(6):1963\u20131971. https:\/\/doi.org\/10.1128\/JCM.40.6.1963-1971.2002","journal-title":"J Clin Microbiol"},{"key":"5556_CR25","doi-asserted-by":"publisher","unstructured":"Jolley K, Bray J, Maiden M (2018) Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 3(124). https:\/\/doi.org\/10.12688\/wellcomeopenres.14826.1","DOI":"10.12688\/wellcomeopenres.14826.1"},{"key":"5556_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/IDR.S191881","volume":"13","author":"N Asgin","year":"2020","unstructured":"Asgin N, Otlu B (2020) Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey. Infect Drug Resist 13:191\u2013198. https:\/\/doi.org\/10.2147\/IDR.S191881","journal-title":"Infect Drug Resist"},{"issue":"12","key":"5556_CR27","doi-asserted-by":"publisher","first-page":"e23541","DOI":"10.1002\/jcla.23541","volume":"34","author":"F Erdem","year":"2020","unstructured":"Erdem F, Kayacan C, Oncul O et al (2020) Clonal distribution of vancomycin-resistant Enterococcus faecium in Turkey and the new singleton ST733. J Clin Lab Anal 34(12):e23541. https:\/\/doi.org\/10.1002\/jcla.23541","journal-title":"J Clin Lab Anal"},{"key":"5556_CR28","doi-asserted-by":"publisher","unstructured":"\u015eenol FF, Tanr\u0131verdi ES, Ayta\u00e7 \u00d6 et al (2023) An outbreak of vancomycin-resistant enterococci in a city hospital intensive care unit: molecular characterization of resistance. Med (Kaunas) 59(12). https:\/\/doi.org\/10.3390\/medicina59122081","DOI":"10.3390\/medicina59122081"},{"issue":"4","key":"5556_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10096-024-04768-0","volume":"43","author":"SN Coccitto","year":"2024","unstructured":"Coccitto SN, Cinthi M, Simoni S et al (2024) Genetic analysis of vancomycin-variable Enterococcus faecium clinical isolates in Italy. Eur J Clin Microbiol Infect Dis 43(4):673\u2013682. https:\/\/doi.org\/10.1007\/s10096-024-04768-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5556_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgar.2017.08.012","volume":"12","author":"I Kilbas","year":"2018","unstructured":"Kilbas I, Ciftci IH (2018) Antimicrobial resistance of Enterococcus isolates in Turkey: A meta-analysis of current studies. J Glob Antimicrob Resist 12:26\u201330. https:\/\/doi.org\/10.1016\/j.jgar.2017.08.012","journal-title":"J Glob Antimicrob Resist"},{"key":"5556_CR31","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.microb.2024.100041","volume":"2","author":"Y Wada","year":"2024","unstructured":"Wada Y, Afolabi HA, Al-Mhanna SB et al (2024) Global occurrence of linezolid-resistant Enterococcus (LRE): The first systematic review and meta-analysis. Microbe 2:100041. https:\/\/doi.org\/10.1016\/j.microb.2024.100041","journal-title":"Microbe"},{"issue":"1","key":"5556_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5578\/mb.68810","volume":"54","author":"\u015eM G\u00f6k","year":"2020","unstructured":"G\u00f6k \u015eM, T\u00fcrk Da\u011f\u0131 H, Kara F et al (2020) Investigation of Antibiotic Resistance and Virulence Factors of Enterococcus faecium and Enterococcus faecalis Strains Isolated from Clinical Samples. Mikrobiyol Bul 54(1):26\u201339. https:\/\/doi.org\/10.5578\/mb.68810","journal-title":"Mikrobiyol Bul"},{"key":"5556_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","volume":"40","author":"JK Bender","year":"2018","unstructured":"Bender JK, Cattoir V, Hegstad K et al (2018) Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug Resist Updat 40:25\u201339. https:\/\/doi.org\/10.1016\/j.drup.2018.10.002","journal-title":"Drug Resist Updat"},{"issue":"Supplement1","key":"5556_CR34","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1093\/ofid\/ofy344","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Cormican M, Flamm RK et al (2019) Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997\u20132016. Open Forum Infect Dis 6(Supplement1):S54\u2013S62. https:\/\/doi.org\/10.1093\/ofid\/ofy344","journal-title":"Open Forum Infect Dis"},{"key":"5556_CR35","doi-asserted-by":"publisher","DOI":"10.36519\/kd.2025.5324","author":"FF Ar\u0131","year":"2025","unstructured":"Ar\u0131 FF, Milletli-Sezgin F (2025) Molecular Detection of Species and Vancomycin Resistance in Enterococci Isolates. Klimik Dergisi\/Klimik J. https:\/\/doi.org\/10.36519\/kd.2025.5324","journal-title":"Klimik Dergisi\/Klimik J"},{"issue":"3","key":"5556_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jinf.2016.11.004","volume":"74","author":"AJ DiPippo","year":"2017","unstructured":"DiPippo AJ, Tverdek FP, Tarrand JJ et al (2017) Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure. J Infect 74(3):243\u2013247. https:\/\/doi.org\/10.1016\/j.jinf.2016.11.004","journal-title":"J Infect"},{"issue":"8","key":"5556_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","volume":"26","author":"J Turnidge","year":"2020","unstructured":"Turnidge J, Kahlmeter G, Cant\u00f3n R et al (2020) Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. Clin Microbiol Infect 26(8):1039\u20131043. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.027","journal-title":"Clin Microbiol Infect"},{"key":"5556_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03029-15","author":"N Jones Ronald","year":"2016","unstructured":"Jones Ronald N, Moeck G, Arhin Francis F et al (2016) Results from oritavancin resistance surveillance programs (2011 to 2014): clarification for using vancomycin as a surrogate to infer oritavancin susceptibility. Antimicrob Agents Chemother 60(5):3174\u20133177. https:\/\/doi.org\/10.1128\/AAC.03029-15"},{"key":"5556_CR39","doi-asserted-by":"publisher","unstructured":"Sefali S, Nakipoglu Y (2024) Efficacy of oritavancin and nisin alone and their combination against vancomycin resistant enterococci strains in hospitalized patients in Turkiye. Indian J Med Microbiol 47:100489. https:\/\/doi.org\/10.1016\/j.ijmmb.2023.100489","DOI":"10.1016\/j.ijmmb.2023.100489"},{"issue":"11","key":"5556_CR40","doi-asserted-by":"publisher","first-page":"E452","DOI":"10.1111\/j.1469-0691.2012.03980.x","volume":"18","author":"T Giani","year":"2012","unstructured":"Giani T, Morosini MI, D\u2019Andrea MM et al (2012) Assessment of the Phoenix automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms. Clin Microbiol Infect 18(11):E452\u2013E458. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03980.x","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5556_CR41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1128\/JCM.41.3.1135-1142.2003","volume":"41","author":"AM Fahr","year":"2003","unstructured":"Fahr AM, Eigner U, Armbrust M et al (2003) Two-Center Collaborative Evaluation of the Performance of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of Enterococcus spp. and Staphylococcus spp. J Clin Microbiol 41(3):1135\u20131142. https:\/\/doi.org\/10.1128\/JCM.41.3.1135-1142.2003","journal-title":"J Clin Microbiol"},{"issue":"9","key":"5556_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1469-0691.2008.02052.x","volume":"14","author":"S Pendle","year":"2008","unstructured":"Pendle S, Jelfs P, Olma T et al (2008) Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak. Clin Microbiol Infect 14(9):853\u2013857. https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02052.x","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"5556_CR43","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1093\/jac\/dkaa180","volume":"75","author":"L Dejoies","year":"2020","unstructured":"Dejoies L, Boukthir S, P\u00e9an de Ponfilly G et al (2020) Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis. J Antimicrob Chemother 75(9):2587\u20132593. https:\/\/doi.org\/10.1093\/jac\/dkaa180","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05556-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:34:50Z","timestamp":1789994090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05556-8","relation":{"references":[{"id-type":"doi","id":"10.1128\/AAC.03029-15","asserted-by":"subject"}]},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Non-Interventional Clinical Research Ethics Board of Hacettepe University (Date: 20.04.2021, Decision No: 2021\/09, GO 21\/558).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}